TransCode Therapeutics, Inc. (RNAZ)
8.63
+0.22
(+2.62%)
USD |
NASDAQ |
Dec 10, 16:00
9.00
+0.37
(+4.29%)
Pre-Market: 09:06
TransCode Therapeutics Shareholders Equity (Quarterly): 1.426M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 16.93B |
| Eli Lilly & Co. | 23.79B |
| Aquestive Therapeutics, Inc. | -4.109M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.227M |
| Total Liabilities (Quarterly) | 3.801M |
| Current Ratio | 1.601 |
| Net Debt Paydown Yield | 0.51% |